Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/172746| Title: | Combined treatment with anti-CD20 (rituximab) and CHOP in relapsed advanced-stage follicular lymphomas |
| Author: | Domingo Domènech, Eva González Barca, Eva Estany, Carla Sureda, Anna Besalduch, Joan Fernández de Sevilla Ribosa, Alberto |
| Keywords: | Anticossos monoclonals Ús terapèutic Limfomes Monoclonal antibodies Therapeutic use Lymphomas |
| Issue Date: | 1-Nov-2002 |
| Publisher: | Ferrata Storti Foundation |
| Abstract: | We studied the safety and efficacy of combined treatment with rituximab plus CHOP in 16 patients with relapsed advanced-stage follicular lymphomas. The intent-to-treat overall response rate (ORR) was 88%, 75% complete remissions (CR) and 13% partial remissions (PR). At a median follow-up of 18 months, 63% of the patients are alive (50% CR). The combination of rituximab and CHOP in relapsed advanced-stage follicular lymphomas achieves high ORRs and CRs, with low toxicity except for in previously autografted patients. |
| Note: | Reproducció del document publicat a: https://haematologica.org/issue/view/99 |
| It is part of: | Haematologica, 2002, vol. 87, num. 11, p. 1229-1230 |
| URI: | http://hdl.handle.net/2445/172746 |
| ISSN: | 0390-6078 |
| Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 519004.pdf | 87.05 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.